Precision Management of a Patient With Dihydropyrimidine Dehydrogenase Deficiency and Liver-Predominant Metastatic Rectal Cancer Using Hepatic Arterial Floxuridine

Affiliations

• ¹ Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
• ² Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, NY.
• ³ Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY.
• ⁴ Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital Memphis, TN.
• ⁵ Department of Clinical Chemistry, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland.
• ⁶ Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.
• ⁷ Department of Clinical Pharmacology, University Hospital, Tübingen, Germany.
• ⁸ Departments of Clinical Pharmacology, and of Biochemistry and Pharmacy, University Hospital, Tübingen, Germany.
• ⁹ Cluster of Excellence iFIT (EXC 2180), "Image-Guided and Functionally Instructed Tumor Therapies," University of Tuebingen, Tuebingen, Germany.
• ¹⁰ Department of Molecular Pharmacology and Experimental Therapeutics and Mayo Clinic Cancer Center, Mayo Clinic, Rochester, MN.
• ¹¹ Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.